UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 10 | October 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 11
November-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2311077


Registration ID:
527240

Page Number

a620-a629

Share This Article


Jetir RMS

Title

Preformulation Studies of Candesartan Cilexetil: Initial Step towards Development of Mouth Dissolving Tablets

Abstract

Introduction: The first stage in creating dosage forms for any pharmacological ingredient is pre-formulation research. It verifies that the compound's development into a commercially available medication is not significantly difficult. Objective: The main objective of this research work was to conduct a pre-formulation analysis of Candesartan Cilexetil an angiotensin receptor blocker drug uses as antihypertensive medicine in order to produce a stable, robust including therapeutically effective system. Methods: Candesartan Cilexetil was analyzed to determine its physiochemical properties. Solubility was also determined in various pH-varying solvents and its purity was determined by FTIR and absorption maxima. Standard calibration curve was developed to aid in further analytical research studies. At last drug-excipients compatibility studies were performed. Results: Organoleptic properties indicated that the drug was almost white in color and odourless. The melting point was recorded at 158.2 ºC. The partition coefficient value log P was found to be 0.59±0.125. The purity of drug was confirmed by infrared spectrum which showed characteristics peaks and by UV spectroscopy which exhibited maxima at 257 nm. The standard curve obtained was linear with correlation coefficient (R2 =0.998) and equation y = 0.033 +0.012. There were no drug excipient interactions which was clear as no visual changes in drug samples were observed with respect to discoloration, liquefaction and odor. Conclusion: The powder blend under consideration was pure Candesartan Cilexetil which had good physiochemical property suggesting use of drug to formulation of novel drug such mouth dissolving tablet by various means and it was stable with selected excipient at reported ratio at 40oC / 75 % RH for 4 weeks.

Key Words

Pre-formulation, Candesartan Cilexetil, excipients, flow property, FTIR

Cite This Article

"Preformulation Studies of Candesartan Cilexetil: Initial Step towards Development of Mouth Dissolving Tablets ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 11, page no.a620-a629, November-2023, Available :http://www.jetir.org/papers/JETIR2311077.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Preformulation Studies of Candesartan Cilexetil: Initial Step towards Development of Mouth Dissolving Tablets ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 11, page no. ppa620-a629, November-2023, Available at : http://www.jetir.org/papers/JETIR2311077.pdf

Publication Details

Published Paper ID: JETIR2311077
Registration ID: 527240
Published In: Volume 10 | Issue 11 | Year November-2023
DOI (Digital Object Identifier):
Page No: a620-a629
Country: Alwar, Rajasthan, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00083

Print This Page

Current Call For Paper

Jetir RMS